Pallas Capital Advisors LLC Takes $513,000 Position in Envista Holdings Corporation $NVST

Pallas Capital Advisors LLC purchased a new stake in Envista Holdings Corporation (NYSE:NVST) during the 2nd quarter, Holdings Channel.com reports. The institutional investor purchased 19,483 shares of the company’s stock, valued at approximately $513,000.

A number of other hedge funds have also bought and sold shares of the business. Dimensional Fund Advisors LP raised its stake in Envista by 1.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 9,780,948 shares of the company’s stock worth $248,130,000 after purchasing an additional 152,488 shares in the last quarter. Alliancebernstein L.P. boosted its stake in shares of Envista by 34.0% in the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock valued at $119,164,000 after buying an additional 1,547,656 shares during the period. Arrowstreet Capital Limited Partnership boosted its stake in shares of Envista by 341.5% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,858,293 shares of the company’s stock valued at $72,515,000 after buying an additional 2,210,847 shares during the period. Quantinno Capital Management LP grew its position in Envista by 38.8% during the first quarter. Quantinno Capital Management LP now owns 2,694,970 shares of the company’s stock worth $68,371,000 after buying an additional 753,474 shares in the last quarter. Finally, Millennium Management LLC grew its position in Envista by 1,442.7% during the fourth quarter. Millennium Management LLC now owns 2,420,615 shares of the company’s stock worth $52,552,000 after buying an additional 2,263,712 shares in the last quarter.

Envista Stock Performance

NYSE NVST opened at $27.61 on Thursday. The firm’s 50 day simple moving average is $26.79 and its 200 day simple moving average is $26.25. The firm has a market capitalization of $4.43 billion, a price-to-earnings ratio of 47.60, a P/E/G ratio of 1.33 and a beta of 0.86. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47. Envista Holdings Corporation has a 1 year low of $18.77 and a 1 year high of $30.42.

Envista (NYSE:NVST) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.34 by $0.07. Envista had a net margin of 3.33% and a return on equity of 7.88%. The business had revenue of $730.50 million during the quarter, compared to the consensus estimate of $716.11 million. During the same period in the previous year, the business earned $0.26 earnings per share. The company’s revenue was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, research analysts expect that Envista Holdings Corporation will post 1.53 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on NVST shares. Evercore reaffirmed an “outperform” rating and issued a $33.00 price objective on shares of Envista in a report on Thursday, May 7th. Robert W. Baird set a $34.00 target price on Envista in a report on Thursday, August 6th. Morgan Stanley set a $23.00 price target on Envista in a research report on Thursday, August 6th. BMO Capital Markets began coverage on Envista in a research note on Wednesday, July 8th. They issued a “market perform” rating and a $27.00 price target for the company. Finally, Piper Sandler reaffirmed a “neutral” rating and set a $28.00 price objective (up from $26.00) on shares of Envista in a research report on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, Envista presently has an average rating of “Moderate Buy” and a consensus target price of $29.31.

Envista Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.